Preoperative C-reactive protein level adjusted for comorbidities and lifestyle factors predicts overall mortality in localized renal cell carcinoma

Molecular Diagnosis and Therapy

Volumn 15, Issue 4, 2011, Pages 229-234

  Michigan, Andrew ^a   Johnson, Timothy V ^a   Master, Viraj A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CANCER MORTALITY; CANCER RELAPSE; CANCER STAGING; COMORBIDITY; FEMALE; HUMAN; INFECTION; INFLAMMATION; INJURY; KIDNEY CARCINOMA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OBESITY; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SMOKING; TUMOR VOLUME;

EID: 80052753569     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.1007/bf03256414     Document Type: Article

References (25)

1. Ramsey S, Lamb GW, Aitchison M, et al. Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer. BJU Int 2008; 101: 959-63 (Pubitemid 351422556)
2. Iimura Y, Saito K, Fujii Y, et al. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score. J Urol 2009; 181: 1004-12; discussion 1012
3. Klatte T, Lam JS, Shuch B, et al. Surveillance for renal cell carcinoma: why and how? When and how often? Urol Oncol 2008; 26: 550-4
4. Ljungberg B. Prognostic markers in renal cell carcinoma. Curr OpinUrol 2007; 17: 303-8 (Pubitemid 47344615)
5. Kavolius JP,Mastorakos DP, Pavlovich C, et al. Resection of metastatic renal cell carcinoma. J Clin Oncol 1998; 16: 2261-6 (Pubitemid 28265066)
6. Karakiewicz PI, Hutterer GC, Trinh QD, et al. C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients. Cancer 2007; 110: 1241-7 (Pubitemid 47435594)
7. Lamb GW, McArdle PA, Ramsey S, et al. The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer. BJU Int 2008; 102: 756-61
8. JabsWJ, Busse M, Kruger S, et al. Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue. Kidney Int 2005; 68: 2103-10 (Pubitemid 43117784)
9. Canna K, McMillan DC, McKee RF, et al. Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer. Br J Cancer 2004; 90: 1707-9 (Pubitemid 38725638)
10. McKeown DJ, Brown DJ, Kelly A, et al. The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer. Br J Cancer 2004; 91: 1993-5 (Pubitemid 40128764)
11. Johnson TV, Abbasi A, Owen-Smith A, et al. Absolute preoperative C-reactive protein predicts metastasis andmortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma. JUrol 2010; 183: 480-5
12. Reichert V, Xue X, Bartscherer D, et al. A pilot study to examine the effects of smoking cessation on serum markers of inflammation in women at risk for cardiovascular disease. Chest 2009; 136: 212-9
13. Ray KK, Cannon CP, Cairns R, et al. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 2005; 46: 1417-24 (Pubitemid 41446175)
14. Ikonomidis I, Lekakis J, Vamvakou G, et al. Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment.Am Heart J 2005; 149: 832-9 (Pubitemid 40718878)
15. Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol 1999; 84: 1018-22 (Pubitemid 29505368)
16. Balagopal P, George D, Patton N, et al. Lifestyle-only intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents. J Pediatr 2005; 146: 342-8 (Pubitemid 40341743)
17. Villareal DT, Miller 3rd BV, Banks M, et al. Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults. Am J Clin Nutr 2006; 84: 1317-23 (Pubitemid 44912812)
18. Nicholls SJ, Tuzcu EM, Sipahi I, et al. Effects of obesity on lipid-lowering, antiinflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL study). Am J Cardiol 2006; 97: 1553-7 (Pubitemid 43737023)
19. Master VA, Johnson TV, Abbasi A, et al. Poorly numerate patients in an inner city hospital misunderstand the American Urological Association symptom score. Urology 2010; 75: 148-52
20. Sobin LH, Fleming ID. TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-4
21. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655-63 (Pubitemid 13234762)
22. Johnson TV, Abbasi A, Owen-Smith A, et al. Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma. Urology 2010; 76: 766. e1-5
23. Johnson TV, Young AN, Osunkoya AO, et al. C-reactive protein as a clinically useful biomarker of metastasis of renal cell carcinoma.Mol Diagn Ther 2010; 14: 191-3
24. Richards CH, Leitch EF, Horgan PG, et al. The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer. Br J Cancer 2010; 103: 1356-61
25. Roxburgh CS, Platt JJ, Leitch EF, et al. Relationship between preoperative comorbidity, systemic inflammatory response, and survival in patients undergoing curative resection for colorectal cancer. Ann Surg Oncol 2011; 18: 997-1005.